tradingkey.logo
tradingkey.logo
検索

Metagenomi Inc

MGX
ウォッチリストに追加
1.130USD
-0.010-0.88%
終値 09-23 16:00ET
42.54M時価総額
損失額直近12ヶ月PER

Metagenomi Incについて 企業名

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed a modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. The Company uses artificial intelligence and its metagenomics platform to develop curative genetic medicines.

Metagenomi Inc プロフィール

企業コードMGX
会社名Metagenomi Inc
上場日Feb 09, 2024
最高経営責任者「CEO」Irish (Jian)
従業員数202
証券種類Ordinary Share
決算期末Feb 09
本社所在地5959 Horton St
都市EMERYVILLE
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号94608
電話番号15108714880
ウェブサイトhttps://metagenomi.co/
企業コードMGX
上場日Feb 09, 2024
最高経営責任者「CEO」Irish (Jian)

Metagenomi Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.43M
+1.46%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
598.72K
-0.36%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
598.72K
-0.36%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
598.72K
-0.36%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.80%
Dr. Laurence E. Reid, Ph.D.
Dr. Laurence E. Reid, Ph.D.
Director
Director
20.00K
--
Dr. Laurence E. Reid, Ph.D.
Dr. Laurence E. Reid, Ph.D.
Director
Director
20.00K
--
Dr. Laurence E. Reid, Ph.D.
Dr. Laurence E. Reid, Ph.D.
Director
Director
20.00K
--
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. (William) Dere, M.D.
Dr. Willard H. (William) Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.43M
+1.46%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
598.72K
-0.36%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
598.72K
-0.36%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
598.72K
-0.36%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.80%
Dr. Laurence E. Reid, Ph.D.
Dr. Laurence E. Reid, Ph.D.
Director
Director
20.00K
--

よくある質問

Metagenomi Incの上位5名の株主は誰ですか?

Metagenomi Incの上位5名の株主は以下のとおりです。Dr. Brian C. Thomas, Ph.D.

Metagenomi Inc(MGX)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Metagenomi Incの株式を保有している機関は172社あり、保有株式の総市場価値は約8.82Mで、全体の23.43%を占めています。2025Q4と比較して、機関の持ち株は-6411264.00増加しています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。